APPB — Applied Biosciences Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.45m
- $0.71m
Annual balance sheet for Applied Biosciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2015 March 31st | R2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0 | 0 | 0.213 | 0.061 | 0.047 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 0 | 0.006 | 0.012 | 0.163 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0 | 0 | 0.258 | 0.227 | 0.354 |
| Net Property, Plant And Equipment | — | — | — | 0.004 | 0.452 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0 | 0 | 1.68 | 0.705 | 3.65 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.013 | 0.008 | 0.032 | 0.036 | 0.374 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | 0.013 | 0.008 | 0.033 | 0.027 | 1.52 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.013 | -0.008 | 1.64 | 0.678 | 2.13 |
| Total Liabilities & Shareholders' Equity | 0 | 0 | 1.68 | 0.705 | 3.65 |
| Total Common Shares Outstanding |